Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 22:14:861350.
doi: 10.3389/fnagi.2022.861350. eCollection 2022.

Harnessing the Power of Leptin: The Biochemical Link Connecting Obesity, Diabetes, and Cognitive Decline

Affiliations
Review

Harnessing the Power of Leptin: The Biochemical Link Connecting Obesity, Diabetes, and Cognitive Decline

Patricia Grasso. Front Aging Neurosci. .

Abstract

In this review, the current understanding of leptin's role in energy balance, glycemic regulation, and cognitive function is examined, and its involvement in maintaining the homeostatic "harmony" of these physiologies is explored. The effects of exercise on circulating leptin levels are summarized, and the results of clinical application of leptin to metabolic disease and neurologic dysfunction are reviewed. Finally, pre-clinical evidence is presented which suggests that synthetic peptide leptin mimetics may be useful in resolving not only the leptin resistance associated with common obesity and other elements of metabolic syndrome, but also the peripheral insulin resistance characterizing type 2 diabetes mellitus, and the central insulin resistance associated with certain neurologic deficits in humans.

Keywords: cognitive function; diabetes; exercise; leptin mimetics; obesity; synthetic peptides.

PubMed Disclaimer

Conflict of interest statement

PG was an unpaid scientific advisor to DIODEM Therapeutics, Inc., Albany, NY, United States

Figures

FIGURE 1
FIGURE 1
Leptin: the biochemical link connecting obesity, diabetes, and cognitive decline. Leptin deficiency (hypoleptinemia) and leptin resistance (hyperleptinemia) are characterized by dysfunctional leptin signaling both centrally and in the periphery. In the brain, dysfunctional leptin signaling in the hypothalamus causes numerous systemic metabolic defects including, but not limited to obesity and diabetes (insulin resistance). Dysfunctional leptin signaling in the hippocampus and cerebral cortex results in the induction and progression of the beta amyloid (Aβ) and Tau pathology associated with Alzheimer’s Disease (AD) and other forms of dementia. Obesity and diabetes are considered significant risk factors for the onset and progression of AD and AD-like cognitive impairment.

Similar articles

Cited by

References

    1. Ahima R. S., Osy S. Y. (2004). Leptin signaling. Physiol. Behav. 81 223–241. 10.1016/j.physbeh.2004.02.014 - DOI - PubMed
    1. Ahima R. S., Kelly J., Elmquist J.l., Flier J. S. (1999). Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 140 4982–4987. 10.1210/endo.140.11 - DOI - PubMed
    1. Anderson B. M., Hirschstein Z., Novakovic Z. M., Grasso P. (2019). MA-[D-Leu-4]-OB3, a small molecule synthetic peptide leptin mimetic, mirrors the cognitive enhancing actions of leptin in a mouse model of type 1 diabetes mellitus and Alzheimer’s Disease-like cognitive impairment. Int. J. Pept. Res. Ther. 26 1243–1249. 10.1007/s10989-019-09929 - DOI
    1. Anderson B. M., Jacobson L., Novakovic Z. M., Grasso P. (2017). Oral delivery of [D-Leu-4]-OB3 and MA-[DLeu-4]-OB3, synthetic peptide leptin mimetics: immunofluorescent localization in the mouse hypothalamus. Brain Res. 1664 1–8. 10.10/j.brainres.2017.03.020 - DOI - PubMed
    1. Araujo-Vilar D., Santini F. (2019). Diagnosis and treatment of lipodystrophy: a step-by- step approach. J. Endocrinol. Invest. 42 61–73. 10.1007/s40618-018-0887-z - DOI - PMC - PubMed

LinkOut - more resources